Raymond James analyst Brian Peterson downgrades UserTesting (NYSE:USER) from Strong Buy to Market Perform.
Axonics Announced First Patient Implants in Canada With New Recharge-Free Sacral Neuromodulation System
Axonics, Inc. (Nasdaq: AXNX) today announced the first patient implants in Canada with the Axonics F15™, the company's newly developed, long-lived, fully recharge-free sacral neuromodulation (SNM) system.